Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Transgene S.A.

Start price
Target price
Perf. (%)
€2.43
07.11.21
€2.80
07.11.22
-20.58%
08.11.22

Could be worthwhile Investment >10% per year
melinda 
07.11.21 50%
buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.40
01.11.21
€15.00
01.11.22
79.03%
02.11.22

Could be worthwhile Investment >10% per year
melinda 
01.11.21 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€7.00
24.10.23
18.42%
29.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
24.10.22 60%
sell
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
18.10.22
-
18.10.23
0.78%
29.10.22

Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
me8 
18.10.22 0%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.54
15.10.22
€2.00
15.10.23
-0.88%
29.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
15.10.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
ngapali 
26.02.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.75
06.10.22
€0.000
06.10.23
-61.11%
24.10.22

Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.10.22 40%
sell
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
melinda 
07.11.21 50%
sell
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
melinda 
17.10.21 50%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€1.03
17.10.21
-
17.10.22
-48.06%
18.10.22

Probably not worthwhile Investment
Lokrim 
17.10.21 10%
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.87
19.09.22
€3.80
19.09.23
0.19%
17.10.22

Could be very worthwhile Investment >20% year
DomRuinart 
19.09.22 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.64
19.09.22
€17.00
19.09.23
-34.41%
17.10.22

Could be very worthwhile Investment >20% year
DomRuinart 
19.09.22 50%
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.41
27.09.22
€11.60
27.09.23
8.69%
17.10.22

Could be very worthwhile Investment >20% year
DomRuinart 
27.09.22 50%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
melinda 
16.10.21 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
michaelkr 
18.05.22 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
08.10.22
€5.00
08.10.23
9.28%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Ruckelsbuckel 
08.10.22 60%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.12
04.09.22
-
04.09.23
-11.64%
15.10.22

Could be worthwhile Investment >10% per year
thomasw 
04.09.22 50%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-15.38%
15.10.22

Risky Investment
Wolf_of_WS 
20.09.22 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
27.08.22 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.10
10.10.21
€15.00
10.10.22
-84.33%
11.10.22

Could be worthwhile Investment >10% per year
Some uniques
yester 
10.10.21 0%
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
BiotechBee 
29.09.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment
quelbe60 
03.10.22 50%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.38
03.10.22
€7.00
03.10.23
-44.51%
06.10.22

Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
me8 
03.10.22 0%
sell
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.76
30.09.22
-
30.09.23
39.41%
03.10.22

Risky Investment
quelbe60 
30.09.22 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€1.88
20.09.22
€1.60
20.09.23
-7.46%
03.10.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
20.09.22 50%